Skip to search formSkip to main contentSkip to account menu

BTK gene

Known as: BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE, Bruton tyrosine kinase, XLA 
This gene is involved in both signaling and B-cell development.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Acalabrutinib (ACP-196) is a second-generation inhibitor of Bruton agammaglobulinemia tyrosine kinase (BTK) with increased target… 
Review
2016
Review
2016
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia and remains incurable outside of the setting of allogeneic… 
2016
2016
ABSTRACT Ibrutinib, a BTK inhibitor, is currently used to treat various hematological malignancies. We evaluated whether… 
Highly Cited
2015
Highly Cited
2015
Despite the therapeutic efficacy of ibrutinib in chronic lymphocytic leukemia (CLL), complete responses are infrequent, and… 
2007
2007
Hypoxia induced mitogenic factor (HIMF) is a member of the FIZZ/resistin/RELM family of proteins that we have shown to have… 
2001
2001
To study the pathophysiology of autosomal recessive polycystic kidney disease (ARPKD), we sought to develop conditionally… 
Highly Cited
1994
Highly Cited
1994
Btk is a cytoplasmic protein tyrosine kinase (PTK) that has been directly implicated in the pathogenesis of X-linked… 
1994
1994
A regional physical and transcription map involving yeast artificial chromosomes (YACs), cosmids, and cDNAs has been constructed… 
1993
1993
Human T cell lymphotropic virus type I (HTLV-I) infection in India has been found to be associated with adult T cell leukaemia…